MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.

Nagi Bioscience

Nagi Bioscience aims to revolutionize the way toxic/beneficial effects of substances are tested today, with the first “Organism-on-Chip” technology. This combines the use of microscopic worms as in vivo models for drug/chemical screening with the first all-in-one device for their automated in vitro handling and use. Finally, “in vivo testing at the in vitro scale”: ethical alternative to animal testing and key to boost innovation and efficiency in pharma, cosmetic, and chemical industries.
We aim to set a new standard for testing toxicity and efficacy of drugs, cosmetics and chemicals: the first “Organism-on-Chip” technology

Connect with Nagi Bioscience

Nagi Bioscience


2018 Finalist Switzerland

Sub industry

Medical Devices

Additional Industries


MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.